Osama E. Rahma

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

Austin G. Duffy, Susanna V. Ulahannan, Oxana Makorova-Rusher et al. · Journal of Hepatology · 2016 · 800 citations · Full text

Hepatology, Medicine, Pathology +6

Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy

Adrienne Luoma, Shengbao Suo, Hannah L. Williams et al. · Cell · 2020 · 446 citations · Full text

Inflammation, Cancer Immunosurveillance, Mucosal Immunology +6

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 316 citations · Full text

Randomized Phase 2, Pancreatic Cancer, Gastrointestinal Oncology +13

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary et al. · The Lancet Oncology · 2020 · 286 citations

Phase 1B, Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma +7

Use of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Osama E. Rahma, Greg Yothers, Theodore S. Hong et al. · JAMA Oncology · 2021 · 178 citations · Full text